pentobarbital will lessen the level or result of cilostazol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital will lessen the level or outcome of methadone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will lessen the extent or outcome of tofacitinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Lack of, or lessened reaction to tofacitinib may perhaps occur when coadministered with potent CYP3A4 inducers
pentobarbital will lessen the level or result of ambrisentan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Not known.
With therapeutic doses of TCAs, barbiturates improve metabolism and decrease blood concentrations of TCAs.
Drugs that have step therapy connected to each prescription. This restriction ordinarily calls for that sure requirements be met just before acceptance for your prescription.
pentobarbital will minimize the extent or result of lefamulin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Stay away from coadministration of lefamulin with sturdy or average CYP3A inducers Except the reward outweighs challenges. Keep track of for minimized efficacy.
Monitor Closely (1)pentobarbital will minimize the level or outcome of gefitinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
Remark: Barbiturates may perhaps raise adverse effects, which includes respiratory despair, made by harmful doses of TCAs. With therapeutic doses of TCAs, barbiturates boost metabolism and decrease blood concentrations of TCAs.
pentobarbital will decrease the extent or influence of tacrolimus by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will reduce the level or influence of cevimeline by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Not known.
pentobarbital will reduce the level or effect get more info of lumacaftor/ivacaftor by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
pentobarbital will lower the extent or outcome of parecoxib by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Watch.
pentobarbital will lower the extent or influence of netupitant/palonosetron by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Netupitant is especially metabolized by CYP3A4; steer clear of use in patients that are chronically making use of a solid CYP3A4 inducer